Affimed Places AFM11 (CD19/CD3-Targeting T cell Engager) Phase 1 Program on Clinical Hold
October 8, 2018
October 8, 2018
August 30, 2018
August 27, 2018
August 8, 2018
August 3, 2018
June 15, 2018
May 30, 2018
May 18, 2018
May 15, 2018
May 8, 2018